tm logo
VYGLEA
Live/Registered
REGISTERED

on 12 Dec 2023

Last Applicant/ Owned by

Ritter House, P.O. Box 173

Road Town, Tortola

VG

VG1110

Serial Number

87729233 filed on 20th Dec 2017

Registration Number

7242841 registered on 12th Dec 2023

in the Principal Register

Correspondent Address

Monica Riva Talley

Filing Basis

1. intent to use

2. use application currently

Disclaimer

NO DATA

VYGLEA

Medicated and pharmaceutical preparations, both prescription and over-the-counter, for use in connection with humans and animals, namely, for the treatment of central nervous system disorders, neurologic illnesses, and psychiatric illnesses pharmaceutical preparations for the treatment of neurodegenerative diseases; pharmaceutical preparations for the treatment of neurodegenerative diseases, namel Read More

Classification Information


Class [005]
Pharmaceutical Products


Medicated and pharmaceutical preparations, both prescription and over-the-counter, for use in connection with humans and animals, namely, for the treatment of central nervous system disorders, neurologic illnesses, and psychiatric illnesses pharmaceutical preparations for the treatment of neurodegenerative diseases; pharmaceutical preparations for the treatment of neurodegenerative diseases, namely, Alzheimer's disease (AD), frontotemporal dementia, cognitive impairment of aging, pharmaceutical preparations for the treatment of pain; pharmaceutical preparations for the treatment of pain, namely, chronic neuropathic pain, peripheral neuropathy, pharmaceutical preparations for symptomatic treatments of degenerative diseases; pharmaceutical preparations for symptomatic treatments of degenerative diseases, namely, dystonias, dysphagia, gait abnormalities, bulbar function in ALS, agitation in AD, disinhibition in dementia; pharmaceutical preparations for the treatment of neuropsychiatric disorders; pharmaceutical preparations for the treatment of neuropsychiatric disorders, namely, Obsessive Compulsive Disorder (OCD), Generalized Anxiety Disorder (GAD), pharmaceutical preparations for the treatment of cerebellar disorders; pharmaceutical preparations for the treatment of cerebellar disorders, namely, spinocerebellar ataxia, pharmaceutical preparations for the treatment of cancer; pharmaceutical preparations for the treatment of cancer, namely, adjunctive use


First Use Date in General

30th Jun 2023

First Use Date in Commerce

30th Jun 2023

Mark Details


Serial Number

No 87729233

Mark Type

No Service/Collective Mark

Attorney Docket Number

No 4501.0070000

44D Filed

No

44D Current

No

44E filed

No

44E Current

No

66A Filed

No

66A Current

No

Current Basis

No

No Basis

No

Legal History


Show more

Status DateAction Taken
12th Dec 2023REGISTERED-PRINCIPAL REGISTER
12th Dec 2023NOTICE OF REGISTRATION CONFIRMATION EMAILED
08th Nov 2023NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
07th Nov 2023ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
23rd Aug 2023STATEMENT OF USE PROCESSING COMPLETE
16th Aug 2023USE AMENDMENT FILED
16th Aug 2023TEAS STATEMENT OF USE RECEIVED
17th Apr 2023APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
17th Apr 2023TEAS CHANGE OF CORRESPONDENCE RECEIVED
17th Apr 2023TEAS CHANGE OF OWNER ADDRESS RECEIVED